Literature DB >> 19571824

Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease.

A Bouazzaoui1, E Spacenko, G Mueller, S Miklos, E Huber, E Holler, R Andreesen, G C Hildebrandt.   

Abstract

Acute graft-versus-host disease (aGVHD) is a major complication after allogeneic bone marrow transplantation (allo-BMT), and infiltration of donor leukocytes into aGVHD target organs is partially orchestrated by chemokines. Using a murine BMT model, the expression of 30 chemokines or chemokine receptors in the lung, liver, gut and tongue was analyzed using real-time PCR at 1, 2, 3 and 6 weeks after BMT during the development of clinical aGVHD and target organ histopathology. CXCL9-11 expression was linked to elevated expression of CXCR3 in the gut, lung and tongue. In contrast, hepatic CXCR3 expression was not changed, whereas a clear association was seen for CXCL16 and CXCR6 expression. An elevated intestinal CCL3 expression 1 week after allo-BMT was associated with an increased expression of CCR5 but not CCR1 or CCR3, and in the lung and liver CCL3-CCL5 expression was associated with increases in CCR1 and CCR5. Overexpression of CCL2, CCL8, CCL12 and their receptor CCR2 was found in the liver and lung, but not in the gut and tongue. On the basis of the differences in kinetics and organ distribution, more studies are required to better characterize specific targets within this network, as this will allow the development of novel preventive and therapeutic approaches by using single or multiple targeting reagents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571824     DOI: 10.1038/gene.2009.49

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  20 in total

Review 1.  Natural killer cell memory.

Authors:  Silke Paust; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

2.  The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.

Authors:  Senthilnathan Palaniyandi; Reena Kumari; Sabarinath Venniyil Radhakrishnan; Ethan Strattan; Natalya Hakim; Reinhold Munker; Melissa V Kesler; Gerhard C Hildebrandt
Journal:  Transplantation       Date:  2020-12       Impact factor: 4.939

3.  TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Reena Kumari; Senthilnathan Palaniyandi; Ethan Strattan; Timothy Huang; Katharina Kohler; Nashwan Jabbour; Joanna Dalland; Jing Du; Melissa V Kesler; Youhai H Chen; Gerhard C Hildebrandt
Journal:  Transplantation       Date:  2020-03       Impact factor: 4.939

Review 4.  The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing.

Authors:  Arthur C Huen; Alan Wells
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

Review 5.  Acute graft-versus-host disease: from the bench to the bedside.

Authors:  Gerard Socié; Bruce R Blazar
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

6.  Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis.

Authors:  Wei Liu; Han-Yun Ren; Yu-Jun Dong; Li-Hong Wang; Yue Yin; Yuan Li; Zhi-Xiang Qiu; Xi-Nan Cen; Yong-Jin Shi
Journal:  Int J Hematol       Date:  2012-11-23       Impact factor: 2.490

7.  Activation of eosinophil CCR3 signaling and eotaxin using a bioinformatics analysis of a mouse model of obliterative airway disease.

Authors:  Amrita Dosanjh
Journal:  J Interferon Cytokine Res       Date:  2014-04-04       Impact factor: 2.607

Review 8.  The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

Authors:  Kenneth R Cooke; Leo Luznik; Stefanie Sarantopoulos; Frances T Hakim; Madan Jagasia; Daniel H Fowler; Marcel R M van den Brink; John A Hansen; Robertson Parkman; David B Miklos; Paul J Martin; Sophie Paczesny; Georgia Vogelsang; Steven Pavletic; Jerome Ritz; Kirk R Schultz; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

9.  The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.

Authors:  Marina G M Castor; Vanessa Pinho; Mauro M Teixeira
Journal:  Front Pharmacol       Date:  2012-02-24       Impact factor: 5.810

10.  Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis.

Authors:  Min Cao; Huihui Liu; Yujun Dong; Wei Liu; Zhengyu Yu; Qingya Wang; Qingyun Wang; Zeying Liang; Yuan Li; Hanyun Ren
Journal:  Stem Cell Res Ther       Date:  2021-07-02       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.